A detailed history of Addison Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Addison Advisors LLC holds 6,905 shares of VTRS stock, worth $89,765. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,905
Previous 2,423 184.98%
Holding current value
$89,765
Previous $25,000 220.0%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$10.32 - $12.13 $46,254 - $54,366
4,482 Added 184.98%
6,905 $80,000
Q2 2024

Aug 05, 2024

BUY
$10.05 - $12.02 $301 - $360
30 Added 1.25%
2,423 $25,000
Q1 2024

May 06, 2024

BUY
$11.27 - $13.53 $1,476 - $1,772
131 Added 5.79%
2,393 $28,000
Q4 2023

Feb 02, 2024

BUY
$8.77 - $10.85 $1,508 - $1,866
172 Added 8.23%
2,262 $24,000
Q3 2023

Nov 07, 2023

BUY
$9.59 - $11.35 $182 - $215
19 Added 0.92%
2,090 $20,000
Q2 2023

Aug 03, 2023

BUY
$9.02 - $10.29 $10,273 - $11,720
1,139 Added 122.21%
2,071 $20,000
Q1 2023

May 09, 2023

SELL
$9.2 - $12.26 $487 - $649
-53 Reduced 5.38%
932 $8,000
Q4 2022

Feb 07, 2023

BUY
$8.72 - $11.56 $4,543 - $6,022
521 Added 112.28%
985 $10,000
Q3 2022

Oct 28, 2022

BUY
$8.48 - $11.13 $737 - $968
87 Added 23.08%
464 $4,000
Q2 2022

Aug 04, 2022

SELL
$9.95 - $12.27 $8,308 - $10,245
-835 Reduced 68.89%
377 $4,000
Q1 2022

Apr 29, 2022

BUY
$9.81 - $15.4 $7,622 - $11,965
777 Added 178.62%
1,212 $13,000
Q4 2021

Jan 31, 2022

BUY
$12.09 - $14.68 $314 - $381
26 Added 6.36%
435 $6,000
Q3 2021

Nov 08, 2021

BUY
$13.25 - $15.13 $53 - $60
4 Added 0.99%
409 $6,000
Q2 2021

Jul 29, 2021

SELL
$12.97 - $16.15 $1,517 - $1,889
-117 Reduced 22.41%
405 $6,000
Q4 2020

Feb 02, 2021

BUY
$14.3 - $18.74 $7,464 - $9,782
522 New
522 $10,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.